1. Technology overview
Fisher & Paykel Healthcare designs and manufactures respiratory care devices and consumables from its head office at 15 Maurice Paykel Place, East Tamaki, Auckland, New Zealand. The company traces its product line to 1969, when its first prototype respiratory humidifier was developed, and now supplies acute and chronic respiratory care, surgery and obstructive sleep apnoea treatment.
Hospital products include the F&P 850 and F&P 950 humidification systems, Optiflow nasal high flow therapy, the F&P Airvo 3 flow generator with an integrated battery for intra-hospital transport, ventilation masks and surgical humidification for laparoscopic procedures. Home and sleep products include PAP therapy masks such as F&P Nova Nasal and F&P Nova Micro. Customers are hospitals, respiratory and intensive care departments, sleep clinics and homecare providers, served through regional operations covering markets in Asia Pacific, Europe and the Americas.
2. Highlighted features & specifications
1. Optiflow: nasal high flow therapy delivered as an alternative to conventional oxygen and non-invasive ventilation.
2. F&P 950 System: next-generation humidifier for invasive and non-invasive respiratory support in hospital.
3. F&P Airvo 3: flow generator with an integrated battery so therapy continues during intra-hospital transport.
4. Sleep apnoea line: PAP interfaces including F&P Nova Micro, the lightest and volumetrically smallest F&P PAP therapy mask.
5. Surgical humidification: dedicated systems for humidifying insufflation gas during laparoscopic surgery.
6. Continuity: respiratory humidification products developed continuously since the first prototype in 1969.
One platform connecting startups, corporations, research institutions, regions and investors
Southeast Asia Innovation Landscape 2026








































